US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Cocaine Dependence Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Cocaine Dependence in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Opioid Addiction Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Opioid Addiction in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Candidiasis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Uterine cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Uterine cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Anthrax Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Sickle Cell Anemia Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Sickle Cell Anemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023
11/1/2014 | published by: GlobalData
... the autoimmune destruction of pancreatic beta cells, which are responsible for producing insulin - a hormone that regulates blood sugar. Type 1 diabetes, formerly referred to as insulin-dependent diabetes, mostly develops in children and young ...  |  read more...
USD 3,995
Bipolar Disorder Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Bipolar Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Bio-Europe 2014 Cancer Drug Pipeline Update
11/3/2014 | published by: BioSeeker Group AB
... accumulated number of ceased drugs over the last years amount to another 784 drugs. Bio-Europe 2014 Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified ...  |  read more...
USD 13,275
Bladder Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of bladder cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 107 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 4,496
Breast Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of breast cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 311 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Colorectal Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of colorectal cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 265 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Gastrointestinal Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of gastrointestinal cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 145 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Leukemia Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... signaling pathways for the treatment of leukemia. The rational for this plethora of treatment strategies is based on our increasing understanding of the 276 drug targets that are included in this drug-pathway analyzing tool. No ...  |  read more...
USD 6,746
Liver Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of liver cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 179 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 4,496
Lung Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of lung cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 324 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Neuroendocrine Tumors Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of neuroendocrine tumors. The rational for this plethora of treatment strategies is based on our increasing understanding of the 79 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 2,246
Renal Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of renal cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 198 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Diabetic Neuropathy Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Diabetic Neuropathy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Kidney Transplantation Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Kidney Transplantation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Liver Fibrosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Liver Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Endometriosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Community Acquired Infections Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Community Acquired Infections in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Urinary Tract Infections Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Urinary Tract Infections in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Dengue Fever Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Dengue Fever in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
1  2  3  4    6    8  9  10